A win-win-win solution that keeps birds healthy, maintains the profitability of your business, and meets consumer demands.
Inteprity is a first-in-class, animal-use only, in-feed antibiotic for the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens in broiler chickens. A win-win-win solution that meets customers' demands without compromising bird health, helping your bottom line.
Necrotic enteritis (NE) is a serious and constant threat to the health and welfare of broiler flocks. Due to the reduction of antibiotic use and increase in coccidiosis vaccination in poultry, the incidence of necrotic enteritis is on the rise, with daily mortality rates as high as 1 percent.1,2
With a Veterinary Feed Directive (VFD), under the supervision of a veterinarian, Inteprity supports bird health and well-being, as a responsible approach to antibiotic use.
Inteprity in the field
An integrated broiler producer conducted a field trial comparing the effects of Inteprity, BMD® and Stafac® on both mortality caused by NE and performance in 21 millions broilers during the summer and fall growing periods.
Additionally, using Inteprity at 22.7 g/ton in the starter feed on days 0-21 (Chart 2) improved weight gain and adjusted feed conversion compared to feeding BMD or Stafac during the same period.
Inteprity now offers expanded feeding flexibility
Inteprity can now be implemented in the feed between Day 0 and Day 18 (fed continuously for 21 days) when fed by itself, or in combination with Maxiban®, Monteban®, Coban® or Bio-Cox® (salinomycin sodium). The Inteprity-Maxiban combination also allows Maxiban to be fed with a zero-day withdrawal when fed according to the label. By utilizing the innovation and flexibility of Inteprity, you can help keep your birds healthy while maximizing profitability.